+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Proteome Sciences Plc (PRM) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 47 Pages
  • October 2024
  • GlobalData
  • ID: 1495420
Proteome Sciences Plc (PRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Proteome Sciences Plc (Proteome Sciences) is a specialized contract research organization (CRO). It outsources services for quantifying proteins and peptides in complex biological samples using advanced mass spectrometry, primarily multiplexed Tandem Mass Tag (TMT) technology. The company identifies protein biomarkers crucial for transforming disease management and addresses unmet medical needs through its expertise in discovery and clinical trials. It serves pharmaceutical companies, biotech firms, and academic institutions, offering services such as sample quality control, proteome characterization, and bioinformatics data interpretation. The company operates through laboratories in Germany and the US. It also designs and manufactures TMT reagents. Proteome Sciences is headquartered in Cobham, England, the UK.

Proteome Sciences Plc Key Recent Developments

  • Sep 13, 2024: Proteome Sciences Announces Interim Results for Six Months Ended June 30, 2024
  • Apr 26, 2024: Proteome Sciences : Substantial contract for Proteome Sciences
  • Apr 10, 2024: Proteome Sciences Announces Final Results for the Year Ended 31 December 2023
  • Jan 02, 2024: Proteome Sciences Announces Completion of new facility in San Diego

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Proteome Sciences Plc - Key Facts
  • Proteome Sciences Plc - Key Employees
  • Proteome Sciences Plc - Key Employee Biographies
  • Proteome Sciences Plc - Major Products and Services
  • Proteome Sciences Plc - History
  • Proteome Sciences Plc - Company Statement
  • Proteome Sciences Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Proteome Sciences Plc - Business Description
  • Other Break-up: Biomarker Services
  • Performance
  • Other Break-up: TMT Royalties
  • Performance
  • Other Break-up: TMT Sales
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: Other
  • Performance
  • Geographical Segment: United Kingdom
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Proteome Sciences Plc - Corporate Strategy
  • Proteome Sciences Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Proteome Sciences Plc - Strengths
  • Proteome Sciences Plc - Weaknesses
  • Proteome Sciences Plc - Opportunities
  • Proteome Sciences Plc - Threats
  • Proteome Sciences Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Recent Developments
  • Sep 13, 2024: Proteome Sciences Announces Interim Results for Six Months Ended June 30, 2024
  • Apr 26, 2024: Proteome Sciences : Substantial contract for Proteome Sciences
  • Apr 10, 2024: Proteome Sciences Announces Final Results for the Year Ended 31 December 2023
  • Jan 02, 2024: Proteome Sciences Announces Completion of new facility in San Diego
  • Aug 25, 2023: Proteome Sciences Announces Interim results for the six months ended 30 June 2023
  • May 12, 2023: Proteome Sciences expands into the US: New Facility to open in San Diego
  • Apr 04, 2023: Proteome Sciences Announces Final Results
  • Jan 05, 2023: Proteome Sciences: Milestone Payment for TMT/TMTpro Sales
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Proteome Sciences Plc, Key Facts
  • Proteome Sciences Plc, Key Employees
  • Proteome Sciences Plc, Key Employee Biographies
  • Proteome Sciences Plc, Major Products and Services
  • Proteome Sciences Plc, History
  • Proteome Sciences Plc, Other Locations
  • Proteome Sciences Plc, Subsidiaries
  • Proteome Sciences Plc, Key Competitors
  • Proteome Sciences Plc, Ratios based on current share price
  • Proteome Sciences Plc, Annual Ratios
  • Proteome Sciences Plc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Proteome Sciences Plc, Performance Chart (2019 - 2023)
  • Proteome Sciences Plc, Ratio Charts

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BioXcel Therapeutics Inc
  • SomaLogic Inc
  • Microsaic Systems plc
  • Eurofins Selcia Limited
  • Aushon BioSystems Inc